c.i. direct blue 1 has been researched along with Spinal Cord Injuries in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellamkonda, RV; Gaupp, E; Karumbaiah, L; Loomis, KH; Pai, SB; Patil, K; Patkar, R; Saxena, T | 1 |
1 other study(ies) available for c.i. direct blue 1 and Spinal Cord Injuries
Article | Year |
---|---|
Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury.
Topics: Animals; Anti-Inflammatory Agents; Drug Carriers; Liposomes; Macrophage Migration-Inhibitory Factors; Male; Mice; Nanostructures; Particle Size; Polyethylene Glycols; Rats; RAW 264.7 Cells; Spinal Cord Injuries; Time Factors; Trypan Blue | 2015 |